Toby M. Ward

741 total citations
19 papers, 614 citations indexed

About

Toby M. Ward is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Toby M. Ward has authored 19 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Toby M. Ward's work include Cancer Cells and Metastasis (4 papers), RNA Research and Splicing (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Toby M. Ward is often cited by papers focused on Cancer Cells and Metastasis (4 papers), RNA Research and Splicing (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Toby M. Ward collaborates with scholars based in United States, United Kingdom and China. Toby M. Ward's co-authors include Elizabeth Iorns, Marc E. Lippman, Mark D. Pegram, Jennifer Clarke, Kerry L. Burnstein, Derek M. Dykxhoorn, Deborah L. Berry, Katherine Drews‐Elger, Xiaosong Chen and Kunwei Shen and has published in prestigious journals such as Advanced Materials, The EMBO Journal and PLoS ONE.

In The Last Decade

Toby M. Ward

19 papers receiving 611 citations

Peers

Toby M. Ward

ONCOL

IMMUN

Francisco J. Cimas Spain

Hyang Sook Seol South Korea

Jean-Philippe Cosse Belgium

Guo‐Kai Feng China

Maggie K. S. Tang Hong Kong

Juan Manuel Iglesias Spain

М. М. Цыганов Russia

Corey Lourenco Canada

Nicola Fenderico Netherlands

Rebecca A. Dagg Australia

Francisco J. Cimas Spain

Toby M. Ward

330 ×0.9

199 ×1.0

ONCOL

93 ×0.5

72 ×1.0

78 ×1.2

IMMUN

Citations per year, relative to Toby M. Ward Toby M. Ward (= 1×) peers Francisco J. Cimas

Countries citing papers authored by Toby M. Ward

Since Specialization

Citations

This map shows the geographic impact of Toby M. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toby M. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toby M. Ward more than expected).

Fields of papers citing papers by Toby M. Ward

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toby M. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toby M. Ward. The network helps show where Toby M. Ward may publish in the future.

Co-authorship network of co-authors of Toby M. Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Toby M. Ward. A scholar is included among the top collaborators of Toby M. Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toby M. Ward. Toby M. Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Ward, Toby M., Jessica Bockhorn, Courtney Schiffman, et al.. (2018). Electrophoretic cytopathology resolves ERBB2 forms with single-cell resolution. npj Precision Oncology. 2(1). 10–10. 13 indexed citations

Liu, Junjun, Xiaosong Chen, Toby M. Ward, Mark D. Pegram, & Kunwei Shen. (2016). Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer. Tumor Biology. 37(7). 9825–9835. 53 indexed citations

Ward, Toby M., et al.. (2016). Abstract 352: HER2 protein isoform heterogeneity investigated by single-cell western blotting. Cancer Research. 76(14_Supplement). 352–352. 1 indexed citations

Duncombe, Todd A., Chi‐Chih Kang, Toby M. Ward, et al.. (2015). Hydrogel Pore‐Size Modulation for Enhanced Single‐Cell Western Blotting. Advanced Materials. 28(2). 327–334. 55 indexed citations

Liu, Junjun, Xiaosong Chen, Toby M. Ward, et al.. (2015). Niclosamide inhibits epithelial-mesenchymal transition and tumor growth in lapatinib-resistant human epidermal growth factor receptor 2-positive breast cancer. The International Journal of Biochemistry & Cell Biology. 71. 12–23. 25 indexed citations

Drews‐Elger, Katherine, Elizabeth Iorns, Philip Miller, et al.. (2014). Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome. Breast Cancer Research and Treatment. 148(1). 41–59. 33 indexed citations

Ward, Toby M., Elizabeth Iorns, Nicholas Hoe, et al.. (2012). Truncated p110 ERBB2 induces mammary epithelial cell migration, invasion and orthotopic xenograft formation, and is associated with loss of phosphorylated STAT5. Oncogene. 32(19). 2463–2474. 34 indexed citations

Iorns, Elizabeth, Katherine Drews‐Elger, Toby M. Ward, et al.. (2012). A New Mouse Model for the Study of Human Breast Cancer Metastasis. PLoS ONE. 7(10). e47995–e47995. 126 indexed citations

Iorns, Elizabeth, Toby M. Ward, Dafydd G. Thomas, et al.. (2012). Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor. Breast Cancer Research and Treatment. 135(1). 79–91. 48 indexed citations

10.

Ward, Toby M., et al.. (2012). The microRNA -23b/-27b Cluster Suppresses the Metastatic Phenotype of Castration-Resistant Prostate Cancer Cells. PLoS ONE. 7(12). e52106–e52106. 74 indexed citations

11.

Jegg, Anna-Maria, Toby M. Ward, Elizabeth Iorns, et al.. (2012). PI3K independent activation of mTORC1 as a target in lapatinib-resistant ERBB2+ breast cancer cells. Breast Cancer Research and Treatment. 136(3). 683–692. 32 indexed citations

12.

Wong, Jenny, Elizabeth Iorns, Michelle N. Rheault, et al.. (2011). Rescue of tropomyosin deficiency in Drosophila and human cancer cells by synaptopodin reveals a role of tropomyosin α in RhoA stabilization. The EMBO Journal. 31(4). 1028–1040. 18 indexed citations

13.

Iorns, Elizabeth, et al.. (2011). Simultaneous analysis of tumor and stromal gene expression profiles from xenograft models. Breast Cancer Research and Treatment. 131(1). 321–324. 8 indexed citations

14.

Iorns, Elizabeth, Toby M. Ward, Nirupa Murugaesu, et al.. (2011). Abstract 4979: Whole genome in vivo RNA interference screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor. Cancer Research. 71(8_Supplement). 4979–4979. 1 indexed citations

15.

Iorns, Elizabeth, H. James Hnatyszyn, Pearl H. Seo, et al.. (2010). The Role of SATB1 in Breast Cancer Pathogenesis. JNCI Journal of the National Cancer Institute. 102(16). 1284–1296. 57 indexed citations

16.

Ward, Toby M., et al.. (2010). Abstract P3-14-14: Activation of SRC and MAPK Mediates Resistance to Lapatinib in ER-/ERBB2+ Breast Cancer. Cancer Research. 70(24_Supplement). P3–14. 1 indexed citations

17.

Ward, Toby M., Marshall V. Williams, Vicki Traina‐Dorge, & Wayne L. Gray. (2009). The simian varicella virus uracil DNA glycosylase and dUTPase genes are expressed in vivo, but are non-essential for replication in cell culture. Virus Research. 142(1-2). 78–84. 12 indexed citations

18.

Ward, Toby M., et al.. (2008). Recombinant simian varicella viruses expressing respiratory syncytial virus antigens are immunogenic. Journal of General Virology. 89(3). 741–750. 10 indexed citations

19.

Gray, Wayne L., et al.. (2006). Simian varicella virus gene 61 encodes a viral transactivator but is non-essential for in vitro replication. Archives of Virology. 152(3). 553–563. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact